Last Call for Abstracts for Inflammatory Bowel Diseases Meeting, AIBD 2016

Last Call for Abstracts for Inflammatory Bowel Diseases Meeting, AIBD 2016
0
(0)

Organizers of the Advances in Inflammatory Bowel Diseases (AIBD 2016) Conference announced that its final date for abstract submission is Sept. 13. AIBD is the Crohn’s & Colitis Foundation of America’s (CCFA) clinical research conference, and is scheduled to take place Dec. 8–10 in Orlando, Florida.

According to a press release, abstracts are still being accepted in the following sessions: clinical, pediatric, basic science and nursing. All submissions are subject to acceptance by the scientific abstract review committee, and those selected for oral or poster presentation will be published in the Inflammatory Bowel Diseases scientific journal.

Researchers who submit abstract proposals will be notified of their acceptance or refusal by Oct. 17.

CCFA is a non-profit, voluntary organization working to find cures for inflammatory bowel diseases (IBD), such as Crohn’s disease, ulcerative colitis (UC), or colon cancer (CC). The foundation works by funding research and providing educational resources for patients and families, as well as for medical professionals and for the public in general. It organizes the AIBD Conference as a way to disseminate research information and build connections within the medical community, ultimately promoting research collaborations.

AIBD is the only conference exclusively for gastroenterologists, pediatric specialists, clinical researchers, nurses, and other healthcare professionals working with pediatric and adult patients with IBD.

The three-day conference will also provide continuing medical education through workshops and four-track format sessions for clinicians, researchers, allied health professionals, nurses, and pediatric gastroenterologists.

AIBD is supported by the American College of Gastroenterology (ACG), the American Gastroenterological Association (AGA), the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), and the British Society of Gastroenterology (BSG).

Attendees can earn up to 20.15 AMA PRA Category 1 Credits, or continuing medical education (CME) credits, depending on the session they choose.

More information on AIBD 2016 abstract submission is available through this link.

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
×
Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
Latest Posts
  • BBT-401 trial data
  • fCAL Elisa protein test
  • Infliximab
  • antibodies, ulcerative colitis

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?